Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Actinium Pharmaceuticals Inc (ATNM)

0.2192   0.006 (2.67%) 06-03 11:55
Open: 0.2195 Pre. Close: 0.2135
High: 0.2239 Low: 0.2116
Volume: 3,438,904 Market Cap: 66M
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's product portfolio includes Iomab-B and Actimab-A.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.22 - 0.221 0.221 - 0.222
Low: 0.207 - 0.209 0.209 - 0.21
Close: 0.208 - 0.21 0.21 - 0.212

Technical analysis

as of: 2020-06-03 11:26:01 AM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 0.26     One year: 0.31
Support: Support1: 0.19    Support2: 0.17
Resistance: Resistance1: 0.22    Resistance2: 0.26
Pivot: 0.20
Moving Average: MA(5): 0.21     MA(20): 0.19
MA(100): 0.22     MA(250): 0.23
MACD: MACD(12,26): 0.01     Signal(9):
Stochastic oscillator: %K(14,3): 84.74     %D(3): 82.07
RSI: RSI(14): 65.68
52-week: High: 0.41  Low: 0.16  Change(%): -19.0
Average Vol(K): 3-Month: 453000  10-Days: 602236

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
ATNM has closed below upper band by 9.7%. Bollinger Bands are 4.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 02 Jun 2020
Is Actinium Pharmaceuticals, Inc. (ATNM) A 'Must-Own' Growth Stock? - The News Heater

Thu, 28 May 2020
Actinium Pharmaceuticals, Inc. (ATNM): What is good about stock? - Marketing Sentinel

Fri, 29 May 2020
Actinium Pharmaceuticals Inc. [ATNM] is -5.37% lower this YTD. Is it still time to buy? - The DBT News

Tue, 19 May 2020
Actinium Pharmaceuticals Inc. (ATNM) moved down -0.02% from 52 weeks low: Is it Too Late to Be Bullish? - State Reviewer

Mon, 01 Jun 2020
How Many Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) Shares Do Institutions Own? - Simply Wall St

Tue, 12 May 2020
Actinium Pharmaceuticals Inc. [ATNM] Is Currently 2.83 above its 200 Period Moving Avg: What Dose This Mean? - The DBT News

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Shares Out. (M) 303
Shares Float (M) 278
% Held by Insiders 0.90
% Held by Institutions 13.90
Shares Short (K) 1,400
Shares Short P. Month (K) 2,370

Stock Financials

EPS -0.147
EPS Est This Year -0.400
EPS Est Next Year -0.250
Book Value (p.s.) 0.030
Profit Margin
Operating Margin
Return on Assets (ttm) -103.9
Return on Equity (ttm) -303.0
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.071
Qtrly Earnings Growth
Operating Cash Flow (M) -21
Levered Free Cash Flow (M) -14

Stock Valuations

PE Ratio -1.49
PEG Ratio
Price to Book value 7.29
Price to Sales
Price to Cash Flow -3.09

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.